China Pharmaceutical Industry Executive Training Program
February 17 - March 2
China currently spends $640 billion on healthcare every year, representing the most significant growth market in the world for the pharmaceutical industry. U.S. pharmaceutical companies, industry associations, and U.S. government agencies interested in accessing this market in China will have the opportunity to connect with 22 senior officials from the China National Medical Products Administration (NMPA) during the NMPA Executive Leadership Training, hosted by the U.S. Trade & Development Agency (USTDA).
The Training will advance global best practices on approving imported pharmaceuticals through networking and information sharing.